It has been found that RERG is hypermethylated and downregulated in colorectal carcinoma [73,74], and the fact that loss of Tks4 resulted in a further reduction in RERG expression is in line with the increased invasion capacity of the Tks4 KO cells. This evidence concerns the gene SH3PXD2B and colorectal carcinoma.